Maternal Health Research Centers of Excellence (U54 Clinical Trial Optional)

Invites applications to participate as a Research Center as part of the Maternal Health Research Centers of Excellence initiative. The purpose of this initiative is to generate innovative approaches to address preventable maternal mortality, decrease severe maternal morbidity, and promote maternal health equity in partnership with communities that are most affected (i.e., Blacks/African Americans, American Indians/Alaska Natives, Hispanics/Latinos, Asian Americans, Native Hawaiians and other Pacific Islanders, sexual and gender minorities, socioeconomically disadvantaged populations, and underserved rural populations). Persons with disabilities are also a priority population. This initiative will use an integrated multi-level approach encompassing structural, social, and biobehavioral research strategies to address the multiple contributing factors that lead to adverse maternal health outcomes and health disparities. Proposed research can address maternal health in the pre-pregnancy, pregnancy, or postpartum period, provided that the research outcomes directly address severe maternal morbidity and/or maternal mortality and equitable health care. This funding opportunity announcement runs in parallel with companion announcements that seek applications for an Implementation Science Hub/Resource Center (RFA-HD-23-037) and a Data Innovation and Coordinating Hub/Resource Center (RFA-HD-23-036). It is expected that all components of the Centers of Excellence, Research Centers, and Hubs, work collaboratively to design and implement research projects, including data collection and data sharing.

Letter of Intent Due Date: November 2, 2022

Deadline: December 5, 2022

PHS 2022-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)

Enables U.S.-owned-and-operated small businesses to conduct research and development that has a strong potential for commercialization. This award and the associated PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) provide funds for small businesses to stimulate technological innovation in the private sector and strengthen the role of small business in meeting federal research and development needs. The related Small Business Technology Transfer announcements [PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) and PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)] aim to foster technology transfer through cooperative research and development between small businesses and research institutions.   

Deadlines: January 5, 2023; April 5, 2023 

Community Partnerships to Advance Science for Society (ComPASS) Program

There are two funding announcements under the ComPASS program: 1) Community-led, Health Equity Structural Intervention Initiative (OT2); and 2) ) Notice of Intent to Publish a Funding Opportunity Announcement for ComPASS Coordination Center (U24 – Clinical Trial Optional). The ComPASS program aims to accelerate the science of health disparities and advance health equity research.

The Community-led, Health Equity Structural Intervention Initiative (OT2) invites applications from community organizations to work in collaboration with their research partners to develop, implement, assess, disseminate, and sustain a community-led health equity structural intervention. The intervention initiative has three phases. It starts with a two-year phase (Phase I) for planning, development, piloting (as appropriate), and building partnerships. It will be followed by a six-year intervention implementation phase (Phase II) and will conclude with a two-year phase (Phase III) for assessment, dissemination, and sustainability efforts. Receipt of an award for Phase I does not guarantee a recipient’s continuation to Phase II or Phase III of the ComPASS Program.

Office Hours: November 8, 2022. The ComPASS program team is hosting Zoom-based office hours for anyone planning to submit a Letter of Intent. Pre-registration is required. Attendees can submit questions prior to the session on the registration form or by emailing CFComPASS@od.nih.gov.

Full Application: The ComPASS team will review the letters of intent and invite select groups to submit a full application.

The ComPASS Coordination Center (CC) will provide administration, coordination, data, and research capacity-building and training support to the ComPASS consortium. The consortium includes both community-led, health equity structural intervention projects that intervene on structural factors that create and perpetuate health inequities and health equity research hubs to provide localized technical assistance to the projects. A single coordination center will be funded as an integral part of the ComPASS Program.

Letter of Intent Due Date: November 18, 2022

Deadline: January 23, 2023